Stories

  1. Publication extender
    Long-term outcomes in IgA nephropathy: Results from the UK National Registry of Rare Kidney Diseases (RaDaR)
  2. Project
    Sparsentan: A novel, non-immunosuppressive, single-molecule, dual endothelin angiotensin receptor antagonist (DEARA) for IgA nephropathy
  3. Project
    Addressing the burden of focal segmental glomerulosclerosis (FSGS) – a rare, progressive, kidney condition
  4. Publication extender
    Mechanism of protective actions of sparsentan in chronic kidney disease models